SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-054193
Filing Date
2007-03-14
Accepted
2007-03-14 10:40:52
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1103321
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2104
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1788
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6658
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6720
6 STATEMENT OF PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 2779
7 STATEMENT OF PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 2768
8 GRAPHIC g91333g41s66.jpg GRAPHIC 39801
9 GRAPHIC g91333g89v90.jpg GRAPHIC 48477
  Complete submission text file 0001193125-07-054193.txt   1249672
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31141 | Film No.: 07692464
SIC: 2834 Pharmaceutical Preparations